LORNOXICAM DRUG PROFILE PDF

Lornoxicam is a non-steroidal anti-inflammatory drug of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. It is available in oral and. Lornoxicam is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory. Lornoxicam is a nonsteroidal anti-inflammatory drug with analgesic properties From: Profiles of Drug Substances, Excipients and Related Methodology,

Author: Mimi Mogal
Country: Bahrain
Language: English (Spanish)
Genre: Relationship
Published (Last): 28 November 2008
Pages: 261
PDF File Size: 12.51 Mb
ePub File Size: 15.42 Mb
ISBN: 668-6-84621-806-4
Downloads: 28613
Price: Free* [*Free Regsitration Required]
Uploader: Kanris

Ganciclovir Lornoxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level. Mesalazine The risk or severity of adverse effects can be increased when Lornoxicam is combined with Mesalazine. Chlorzoxazone Lornoxicam may decrease the excretion rate of Chlorzoxazone which could result in prifile higher serum level.

There was a problem providing the content you requested

Dipotassium phosphate Dipotassium phosphate may increase the hyperkalemic activities of Lornoxicam. Bendazac The risk or severity of profle effects can be increased when Lornoxicam is combined with Bendazac. Manidipine The therapeutic efficacy of Manidipine can be decreased when used drgu combination with Lornoxicam.

Amitriptyline Lornoxicam may decrease the excretion rate of Amitriptyline which could result in a higher serum level. Fluconazole The metabolism of Lornoxicam can be decreased when combined with Fluconazole. Chondroitin sulfate Lornoxicam may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.

Gadofosveset trisodium Lornoxicam may decrease the excretion rate of Gadofosveset trisodium druy could result in a higher serum level. Gimeracil Lornoxicam may decrease the excretion rate of Gimeracil which could result in a higher serum level. Celiprolol Lornoxicam may decrease the antihypertensive activities of Celiprolol.

Estradiol Lornoxicam may decrease the excretion rate of Estradiol which could result in a higher serum level.

Escitalopram The risk or severity of gastrointestinal bleeding and gastrointestinal ulceration can loroxicam increased when Escitalopram is combined with Lornoxicam. Benazepril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Lornoxicam is combined with Benazepril.

  BROTHER MFC 665CW MANUAL PDF

Betamethasone The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Lornoxicam. Cilnidipine The risk or lornoxjcam of hyperkalemia can be increased when Lornoxicam is combined with Cilnidipine. Chromic chloride Lornoxicam may decrease the excretion rate of Chromic chloride which could result in a higher serum level.

Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Lornoxicam.

Lornoxicam drug information | DrugsUpdate India

Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Lornoxicam. Medindia Drug Information Lornoxicam. Antithrombin Alfa The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Antithrombin Alfa. Cefuroxime The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Lornoxicam.

Lornoxicam – DrugBank

lornnoxicam Bismuth subgallate Lornoxicam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level. Disopyramide Lornoxicam may decrease the excretion rate of Disopyramide which could result in a higher serum level. Fenofibrate Lornoxicam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.

Asunaprevir The metabolism of Druy can be decreased when combined with Lornoxicam. Mephenytoin The metabolism of Lornoxicam can be decreased when combined with Mephenytoin. Imidapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Lornoxicam is combined with Imidapril. Most Popular On Medindia: Amineptine The risk or severity of hypertension can be increased when Amineptine is combined with Lornoxicam. Iofetamine I The risk or severity of hypertension can be increased when Lornoxicam is combined with Iofetamine I Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Lornoxicam.

Diphenhydramine The metabolism of Lornoxicam can be decreased when combined with Diphenhydramine.

Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Lornoxicam. Chlorthalidone The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Lornoxicam.

Lornoxicam is used for the treatment of various types of pain, especially resulting from inflammatory diseases of the joints, osteoarthritissurgery, sciaticaand other inflammations. Ertapenem Lornoxicam may decrease the excretion rate of Ertapenem which could result in a higher serum level. Azelastine The metabolism of Lornoxicam can be decreased when combined with Azelastine. Epirizole The risk or severity of adverse effects can be increased when Lornoxicam is combined with Epirizole.

  EXR 1581 PDF

This site complies with the HONcode standard for trustworthy health information: Baclofen Lornoxicam may decrease the excretion rate of Baclofen which could result in a higher serum level. Lomerizine The risk or severity of hyperkalemia can be increased when Lornoxicam is combined with Lomerizine.

Estrone sulfate Lornoxicam may decrease the excretion rate of Estrone sulfate which could result in a higher serum level. Items listed in bold indicate initially developed compounds of specific groups.

Difloxacin Lornoxicam may increase the neuroexcitatory activities of Difloxacin. Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a property that explains the particularly pronounced efficacy of the drug.

Dichlorobenzyl alcohol Lornoxicam may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level. Excretion Excreted in the faeces as metabolites and urine as unchanged drug.

Levomenthol The risk or severity of hyperkalemia can be increased when Menthol is combined with Lornoxicam. Glipizide The protein binding of Glipizide can be decreased when combined with Lornoxicam.

Iopromide Lornoxicam may decrease the excretion rate of Iopromide which could result in a higher serum level.

Inosine pranobex Lornoxicam may decrease the excretion rate of Inosine pranobex which could result in a higher serum level. Lurasidone The risk or severity of hypertension can be increased when Lornoxicam is combined with Lurasidone.

Desmoteplase The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Desmoteplase.